Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

EMBO reports·2026
Same author

Knowledge and Attitudes Toward Sexual and Reproductive Health Among Adolescents Studying in Government Schools in Tansen Municipality, Palpa, Nepal: A School-Based Cross-Sectional Study.

Public health challenges·2026
Same author

On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases.

Journal of medicinal chemistry·2026
Same author

p21-Activated Kinase (PAK) Group I-Targeting Inhibitors Promote the Dimeric Conformation in Live Cells.

ACS chemical biology·2026
Same author

The structural basis for LRRK2's activation and autoinhibition.

bioRxiv : the preprint server for biology·2026
Same author

First Structure-Activity-Relationship Study of Potent G2A Antagonists.

Journal of medicinal chemistry·2026
Same journal

Intracellular Delivery of Peptides and Proteins with an Engineered Membrane Translocation Domain.

ACS chemical biology·2026
Same journal

Development of Next-Generation Fluoroacetamidine-Containing Activity-Based Probes for the Selective Labeling of the Protein Arginine Deiminases (PADs).

ACS chemical biology·2026
Same journal

Spectroelectrochemical Insight into Reaction Mechanisms of Cell-Penetrating Peptides on Charged Membrane Surfaces.

ACS chemical biology·2026
Same journal

Metal- and Redox-Dependent Oxytocin Species Differentially Regulate Invasion and Migration in Triple-Negative Breast Cancer.

ACS chemical biology·2026
Same journal

A Systematic Direct-to-Biology Approach Identified Potent Cereblon HaloPROTACs.

ACS chemical biology·2026
Same journal

Resistance-CONKAT-seq Guided Discovery of a ClpP Active Natural Product from a Soil Metagenome.

ACS chemical biology·2026
查看所有相关文章

相关实验视频

Updated: Jun 12, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.1K

工作流程 E3 联酶联物质验证 PROTAC 开发.

Nebojša Miletić1,2, Janik Weckesser1,2, Thorsten Mosler3

  • 1Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

ACS chemical biology
|February 11, 2025
PubMed
概括
此摘要是机器生成的。

本研究引入了一种简化的工作流程,用于评估E3结合酶连接体在蛋白质溶解向嵌合体 (PROTACs) 开发中的作用. 它强调了有效的链接器附着点用于酶降解,并确定了细胞毒性作为VHL独立降解的陷.

更多相关视频

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

313

相关实验视频

Last Updated: Jun 12, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.1K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

313

科学领域:

  • 药物发现和开发 药物发现和开发
  • 分子生物学分子生物学
  • 生物化学 生物化学

背景情况:

  • 针对蛋白质溶解的嵌合体 (PROTACs) 代表了一种新的药物发现模式.
  • 目前的PROTAC开发主要使用Cereblon (CRBN) 和Von Hippel-Lindau (VHL) E3结合酶结合体.
  • 人类广泛的E3酶家族为具有独特特性的新型降解剂提供了潜力.

研究的目的:

  • 开发和验证一个简化的工作流程,以评估在PROTAC开发中的E3酶连接体效率.
  • 评估"可降解"的目标空间使用激酶抑制剂和VHL连接体VH032.2.
  • 识别蛋白质降解试验中的潜在陷.

主要方法:

  • 开发一个工作流程来评估E3结合酶结合物的效率.
  • 使用广谱激酶抑制剂和VHL配体VH032作为验证系统.
  • 采用了E3酶连接体负对照,竞争测试,以及无和蛋白质酶通路的抑制剂.

主要成果:

  • 确定了VH032链接器附着点,它们对酶降解非常有效.
  • 揭示了细胞毒性作为导致PROTAC和VHL独立的激酶降解的重要机制.
  • 确立了控制和抑制剂的必要性,以区分依赖VHL和独立于VHL的降解.

结论:

  • 开发的工作流程有助于评估PROTAC开发的E3酶连接体效率.
  • 细胞毒性可能会混蛋白质降解读数,需要仔细的实验设计.
  • 这项研究为未来对降解性发育中的新型E3结合酶结合体系统的评估提供了指导.